July 2023 — This fact sheet provides basic information to raise awareness of injectable cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) among transgender and gender-nonbinary advocates and community members. It also describes actions transgender and gender-nonbinary people can take to advocate for the approval and availability of CAB for PrEP in their country in the Asia Pacific region.
